Cardiac Drug Safety (Record no. 90410)

MARC details
000 -LEADER
fixed length control field 05764cam a2200637Mi 4500
001 - CONTROL NUMBER
control field ocn794328376
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20221128211740.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|---|||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120528s2012 si ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EBLCP
019 ## -
-- 793804672
-- 794902679
-- 797852507
-- 817084766
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9789814317467
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9814317462
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1280669225
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781280669224
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9789814317450
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9814317454
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)794328376
Canceled/invalid control number (OCoLC)793804672
-- (OCoLC)794902679
-- (OCoLC)797852507
-- (OCoLC)817084766
043 ## - GEOGRAPHIC AREA CODE
Geographic area code n-cn---
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code TEC
Subject category code subdivision 010010
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MMG
Source bicssc
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
100 1# - MAIN ENTRY--PERSONAL NAME
Personal author Killeen, Matthew J.
245 10 - TITLE STATEMENT
Title Cardiac Drug Safety
Medium [electronic resource] :
Subtitle a Bench to Bedside Approach.
260 ## - PUBLICATION INFORMATION
Place of publication Singapore :
Publisher World Scientific,
Date 2012.
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource (189 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - CONTENTS
Contents Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels.
505 8# - CONTENTS
Contents Calcium channelsPotassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References.
505 8# - CONTENTS
Contents Chapter 4 The Mechanisms Underlying Cardiac ArrhythmiasIntroduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed Afterdepolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts.
505 8# - CONTENTS
Contents Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse ModelSummary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction.
505 8# - CONTENTS
Contents Preclinical Evaluation of Cardiac Drug SafetyThe ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia.
500 ## - GENERAL NOTE
General note Variability of repolarization.
520 ## - ABSTRACT
Abstract Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk of encountering this major adverse event continues to shape the drug development and regulatory landscape. Extensive research over the past decade has shed light on the root causes of arrhythmias that are triggered by medications and has helped drive, and optimize, drug safety testing. However, curr.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
650 #0 - SUBJECT HEADINGS
Subject term Arrhythmia
General subdivision Treatment.
650 #0 - SUBJECT HEADINGS
Subject term Drugs
General subdivision Safety regulations
Geographic subdivision Canada.
650 #2 - SUBJECT HEADINGS
Subject term Heart
General subdivision drug effects.
650 #2 - SUBJECT HEADINGS
Subject term Drug Toxicity
General subdivision prevention & control.
856 40 - ONLINE RESOURCE
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=457178">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=457178</a>
Link text Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
938 ## -
-- 123Library
-- 123L
-- 114800
938 ## -
-- Coutts Information Services
-- COUT
-- 23981151
938 ## -
-- EBL - Ebook Library
-- EBLB
-- EBL919080
938 ## -
-- ebrary
-- EBRY
-- ebr10563572
938 ## -
-- EBSCOhost
-- EBSC
-- 457178
938 ## -
-- Ingram Digital eBook Collection
-- IDEB
-- 364615
938 ## -
-- YBP Library Services
-- YANK
-- 7280427
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library Stenhouse Library   28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=457178 28/11/2022 Electronic book
London Health Libraries Koha Consortium privacy notice